We demonstrated previously that inhibition of the small GTPase Rac-1 by C. sordellii lethal toxin (LT) increased the hydraulic conductivity (Lp) of rat venular microvessels and induced gap formation in cultured myocardial endothelial cells (MyEnd). In MyEnd cells we also demonstrated that both LT and cytochalasin D reduced cellular adhesion of VE-cadherincoated beads. Here we further evaluate the contribution of actin depolymerization, myosinbased contraction, and VE-cadherin linkage to the actin cytoskeleton to LT-induced permeability. The actin-depolymerizing agent cytochalasin D increased Lp in single rat mesenteric microvessels to the same extent as LT over 80 min. However, whereas the actin stabilizing agent jasplakinolide blunted the Lp increase due to cytochalasin D by 78 %, it had no effect on the LT response. This conforms to the hypothesis that the predominant mechanism whereby Rac-1 stabilizes the endothelial barrier in intact microvessels is separate from actin polymerization, and likely at the level of the VE-cadherin linkage to the actin cytoskeleton. In intact vessels, neither inhibition of contraction (butanedione-monoxime, BDM, an inhibitor of myosin ATPase) nor inhibition of Rho kinase (Y-27632) modified the response to LT, even though both inhibitors lowered resting Lp. In contrast BDM and inhibition of MLCK completely inhibited LT-induced intercellular gap formation and largely reduced the LT-induced permeability increase in MyEnd monolayers. These results support the hypothesis that the contractile mechanisms that contribute to the formation of large gaps between cultured endothelial cells exposed to inflammatory conditions do not significantly contribute to increased permeability in intact microvessels. Waschke et al. 
Introduction
In previous studies from our laboratories, we have shown that inhibition of the small GTPase, Rac-1, using C. sordellii lethal toxin (LT) increases rat and mouse mesenteric microvessel permeability (measured as an increase in hydraulic conductivity) to the same extent as inhibition of all the small GTPases using toxin B (1, 23) .The results were consistent with the hypothesis that Rac-1 may be essential to maintain normal permeability and that inhibiting Rac-1, and not an activation of other GTPase-dependent mechanisms may be important to increase permeability in intact microvessels. Thus further understanding of the mechanisms whereby Rac-1 modulates permeability is needed. The present experiments examine further the role of cell-cell adhesion, contractile mechanisms, and re-organization of the actin cytoskeleton in Rac-1-dependent regulation of permeability. They also develop further the strategy in our laboratories in Wuerzburg and Davis to design, as near as is currently possible, parallel experiments under similar experimental conditions to investigate the modulation of the endothelial barrier function in cultured endothelial cell monolayers and intact microvessels. This approach enables us to evaluate the contribution of mechanisms studied in vitro to the regulation of permeability in intact microvessels.
In previous investigations to understand the role of Rac-1 in permeability regulation we carried out experiments to inhibit Rac-1 in cultured mouse endothelial cells parallel to those in intact microvessels. From studies using cultured epithelial cells, a role of Rac-1 in the stabilization of the adherens junction is known and it has been demonstrated that Rac-1 is activated upon establishment of new adherens junctions via recruitment of a GTPase exchange factor which in turn activates Rac-1 (12). In cultured mouse endothelial cells we found similar strong evidence for a role for Rac-1 to regulate cell-cell adhesion (23).
Inhibition of Rac-1 with LT reduced binding of VE-cadherin-coated microbeads to the surface of endothelial cells as revealed by laser tweezer assays, suggesting that reduced VE-cadherinmediated cell-cell adhesion takes part in the mechanisms to increase permeability. If similar mechanisms acted in intact microvessels, these experiments suggested that Rac-1dependent mechanisms which control cell-cell adhesion may be necessary to maintain normal permeability. The limitation on this conclusion was that in cultured endothelial cells we also found that both actin re-organisation and contractile mechanisms contributed to the changes in the endothelial barrier after Rac-1 inhibition. The present experiments were designed to follow up these observations by investigating: (1) the effect of actin de-polymerization in intact microvessels under conditions similar to those found with Rac-1 inhibition; (2) the effect of inhibition of contractile mechanisms on the LT-induced increase in microvesssel permeability, and (3) idea that the formation of large gaps in cultured monolayers may not be the most reliable test for the contribution of myosin based contractile mechanisms to increase permeability. Specifically we have argued that large gaps may not be representative of physiological mechanisms regulating permeability, and that an evaluation of the contribution of contractile mechanism based on the presence or absence of large gaps in the barrier may overestimate the contribution of contractile mechanisms to the action of small GTPases.
To test the action of Rac-1 inhibition on actin depolymerization, we build on previous investigations in the Wuerzburg laboratory (5,6,7) which demonstrated that the anchorage of VE-cadherin to the actin cytoskeleton (see also Fig. 6 ) is crucial for VE-cadherin-mediated adhesion, because of the extremely low affinity (millimolar range) and half-life of single VEcadherin bonds (about half a second). This was demonstrated, in part, by measuring adhesion of VE-cadherin-ectodomain-coated beads to the endothelial cell surface after actin breakdown by cytochalasin D. The effects of the actin-destabilizing agent cytochalasin D on VEcadherin-mediated adhesion were completely inhibited by prior stabilization of actin filaments with jasplakinolide. On the basis of this result we predicted that, if inhibition of Rac-1 decreased VE-cadherin-dependent adhesion by depolymerizing actin, the action of LT should be completely reversed by the actin-stabilizing agent jasplakinolide. One specific aim of the present investigations was to test this prediction in intact microvessels. We have also followed up the observation that, in cultured mouse endothelial cells, the effect of inhibiting Rac-1 with LT on VE-cadherin-coated bead adhesion could not be inhibited completely by jasplakinolide, suggesting additional mechanisms independent of actin depolymerization in vitro (23).
One of the additional mechanisms to disrupt the barrier after Rac-1 inhibition in cultured endothelial cells appeared to involve a contribution from actin-myosin contraction, because the formation of large gaps between adjacent endothelial cells after inhibition of Rac-1 was blocked by inhibiting actin-myosin contraction. Therefore, a second aim of the current experiments was to evaluate the contribution of contractile mechanisms to the increase in permeability after Rac-1 inhibition in both microvessels and cultured endothelial cells. We did this by measuring increased permeability in both microvessels and cultured endothelial monolayers induced by inhibiting Rac-1 in the presence and absence of inhibitors of contractile mechanisms as well as observing the formation of large gaps in cultured monolayers under the same conditions.
Materials and Methods
Cell culture: The immortalized mouse microvascular endothelial cell line (MyEnd) was grown in Dulbeccos modified Eagles medium (DMEM, life technologies, Karlsruhe, Germany) supplemented with 50 U/ml penicillin-G, 50 µg streptomycin and 10 % fetal calf serum (FCS) (Biochrom, Berlin, Germany) in a humidified atmosphere (95 % air/ 5 % CO 2 ) at 37 °C. Generation and characterisation has been described before (1, 14) . In brief, myocardial tissue of newborn mice was minced, digested with 0.05 % trypsin (Biochrom, Berlin, Germany) and 0.02 % collagenase (Boehringer, Mannheim, Germany), and seeded onto gelatine-coated culture dishes. One day after plating, adherent cells were transfected with Hydraulic conductivity (Lp) was estimated for each occlusion as (J v /S)/ P eff. . All perfusates were mammalian Ringer solution additionally containing serum albumin at 10 mg/ml (Sigma A 4378). LT was added to the perfusate and delivered via the micropipette continuously.
Measurements of (J v /S) 0 were made at approximately 10 min intervals for up to 90 min in 9 presence and absence of LT. In preliminary experiments LT at 100 ng/ml was perfused through 2 venules for 150 min with no change from baseline Lp. Therefore, we used 200 ng/ml LT for subsequent venule perfusion experiments as described previously (23).
Jasplakinolide (0.1 µM), Y-27632 (30 µM) and BDM (5 mM) were applied simultaneously or prior to LT without significant differences. BDM and jasplakinolide were used alone for control experiments as indicated. Cytochalasin D was used at 10 µM because 2 preliminary experiments indicated no difference between 1 µM and 10 µM and we previously used the latter concentration for our in vitro experiments (5, 23).
Statistics: Values throughout are expressed as mean ± standard error. Baseline Lp distributions are non-Gaussian in both frog mesentery capillaries and rat mesentery venules (16, 18). Because Lp distribution under conditions of the present experiments has not been investigated we used the non-parametric Mann-Whitney statistic to test for differences in Lp between groups. Possible differences between groups in bead binding and macromolecular flux across cultured endothelial cell monolayers were assessed using unpaired Student's t-test.
Statistical significance is assumed for p < 0.05.
Results

LT and cytochalasin D drastically increase hydraulic conductivity (Lp)
To evaluate the contribution of actin depolymerization to permeability increases in perfused rat microvessels we compared the increase in to LT no lag phase was observed (Fig. 1b) . Controls in which the vessels were perfused without LT showed no increase of Lp during this time course, as previously published (1).
Stabilization of F-actin does not block the effect of LT on hydraulic conductivity (Lp)
Stabilization of the actin cytoskeleton with jasplakinolide (0.1 µM) did not reduce the effect of LT as Lp rose to 170.3 ± 1.0 x 10 -7 cm/ (sec cmH 2 O) after 80 min (n = 5). In fact, this mean value was significantly higher than in the experiments using LT alone at 80 min. A typical experiment is shown in Fig. 2a . In contrast, when cytochalasin D and jasplakinolide were applied together (Fig. 2 b) , Lp increased significantly less, to only 31.9 ± 7.7 x 10 
Myosin-dependent contraction is not required for the LT-induced permeability increase in vivo
To test whether myosin-dependent contraction is required for the LT-induced increase of microvessel hydraulic conductivity we perfused rat mesenteric microvessels with the inhibitor cm/ (sec cmH 2 O) and to 0.8 ± 0.1 x 10 -7 cm/ (sec cmH 2 O), respectively (Fig. 3 c) . This corresponds to a reduction to about 50 % of the control value and was comparable to the effect of Y-27632 and ML-7 on microvascular baseline Lp (1, 2). These experiments indicate that a myosin-based contractile mechanism is active in endothelial cells that regulates baseline permeability but is not required for the permeability increase in response to LT.
ML-7 and BDM but not Y-27632 block LT-induced intercellular gap formation in vitro
LT-induced gap formation (200 ng/ml, 120 min) in cultured MyEnd cells was accompanied by the formation of particularly thick stress fibers (Fig. 4 g ). Sites of gap formation were characterized by the absence of VE-cadherin immunostaining (Fig. 4 b) whereas VE-cadherin was distributed uniformly along the intercellular junction in control cells (Fig. 4 a) . Too see whether LT-induced gap formation was caused by myosin-based contraction we incubated monolayers with ML-7, an inhibitor of myosin light chain kinase (MLCK), or butanedione-
monoxime (BDM), an inhibitor of myosin-ATPase in combination with LT. None of the inhibitors when applied alone changed the distribution of VE-cadherin (not shown). Y-27632
(30µM), used at concentrations where it was effective to completely abolish stress fibers in
MyEnd cells when applied alone (23), did not reduce LT-induced gap formation. Cells still displayed remodelling of the stress fiber system from numerous thin stress fibers to fewer but much thicker fibers. In addition, fragmentation of the VE-cadherin immunostaining became obvious (Fig. 4 c and h ) indicative for the effect of LT. In contrast treatment of MyEnd cells with ML-7 or BDM in sequence or together with LT completely abolished intercellular gap formation as well as fragmentation of the junctional band of VE-cadherin (Fig. 4 d, e) . ML-7, when applied together with LT, reduced the amount of stress fibers compared to both control cells and cells treated with LT alone (Fig. 4 i) which indicates inhibition of MLCK since phosphorylation of myosin regulatory light chain is required for stress fiber formation (8). In contrast, BDM did not reduce stress fiber remodelling induced by LT indicating that inhibition of myosin ATPase did not effect stress fiber formation (Fig. 4 j) . In contrast to our in vivo experiments these data suggest that LT-induced formation of large intercellular gaps requires generation of contractile force in cultured endothelial cells. Further, because inhibitors of contractile mechanisms inhibited gap formation, these data suggest that inhibition of contractile mechanisms might attenuate increased permeability to macromolecules if gap formation were a reliable index of changes in permeability.
BDM reduces LT-induced loss of barrier function of cultured endothelial cells in vitro
To test the idea that actin-myosin contraction was an important mechanism to increase permeability in cultured endothelial cells after LT inhibition, and to better compare the relative contribution of myosin-dependent contractile mechanisms to the LT-induced permeability changes in vivo and in vitro, transwell filter experiments using cultured MyEnd monolayers were performed. The activity of LDH in the lower chamber of control monolayers at 5 min was 0.003 ± 0.013 (n = 6) units. For monolayers exposed to LT for 120 min prior to flux assay, the activity was 1.01 ± 0.156 (n = 6) units, about 340 times the control value. This high increase reflected the large gaps visible by immunostaining of MyEnd monolayers in parallel experiments (Fig. 4 b) . When MyEnd cells were incubated with LT in the presence of BDM (120 min), LDH activity was 0.105 ± 0.076 (n = 6), 35 times above control but nearly 10-fold less than with LT alone. No large gaps were found in the monolayers treated with BDM (Fig.4 e) . This accumulation of LDH was significantly different from control values, and demonstrates that contraction-independent mechanisms to increase monolayer clearance are present and may not be identified if only large gap formation is used as a criterion for changes in endothelial barrier integrity.
The effect of LT on VE-cadherin-mediated adhesion is not modulated by ML-7, BDM or Y-27632
We tested whether inhibitors of myosin-dependent contraction modified the adhesion of VE To investigate these possibilities we tested the action of the actin depolymerizing-agent cytochalasin D at a concentration where it produced an increase in microvessel permeability similar to that caused by LT and they both decreased cellular actin content by about 50 % (23). As expected, stabilization of actin filaments with jasplakinolide blunted the effect of cytochalasin D on microvessel permeability. This conforms to our previous studies where jasplakinolide completely inhibited the weakening of VE-cadherin-coated bead adhesion in vitro (7, 23). The fact that jasplakinolide did not completely inhibit the effect of cytochalasin D might be attributed to the lower dose we applied for the in vivo experiments. Microvessel endothelium was found to be extremely sensitive to jasplakinolide leading to destabilizing effects of jasplakinolide on barrier functions when applied at the higher concentrations used in our previous study. In contrast, actin stabilization did not inhibit the effect of LT on microvessel Lp and only partially blocked the effect of LT on VE-cadherin-mediated adhesion. This indicates that the signalling pathway regulated by Rac-1 is, at least in part, separate from an action on the actin cytoskeleton, and it is likely that this involves the anchorage of VE-cadherin to the cytoskeleton via the adaptor molecules of the catenin family (Fig. 6) . One possible mechanism is that Rac-1 regulates anchorage via the protein IQGAP-1. (Fig. 6 ).
Permeability increase in vivo does not require myosin-dependent contraction
Our study indicates that myosin-dependent contraction is not needed to increase permeability It should be noted that other mechanisms may also regulate actin-myosin contraction, and these may be involved in the action of Rac-1. In cultured MyEnd cells, thick stress fiber bundles appeared in response to inhibition of Rac-1. This remodelling of the stress fiber system was inhibited by treatment with ML-7 along with the inhibition of gap formation.
However, stress fiber remodelling and gap formation was not inhibited by Y-27632. This suggests that stress fiber formation is not caused by activation of Rho but by direct signalling events through Rac-1 that may lead to activation of MLCK. It has been suggested that p21-activated kinase (PAK), an effector kinase of Rac-1, takes part in this process (13, 25). 
